Aster Dm Healthcare Stock Target Price

ASTERDM Stock   433.45  2.80  0.65%   
Aster DM Healthcare fundamentals help investors to digest information that contributes to Aster DM's financial success or failures. It also enables traders to predict the movement of Aster Stock. The fundamental analysis module provides a way to measure Aster DM's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aster DM stock.
Short Long Term Debt TotalTotal Assets27.9B56.0B48.0B49.1B57.0B13.8B15.9B31.7B89.4B124.4B116.4B125.5B148.8B179.9B206.9B217.2B100%
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Aster Target Price Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aster DM's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aster DM could also be used in its relative valuation, which is a method of valuing Aster DM by comparing valuation metrics of similar companies.
Aster DM is currently under evaluation in target price category among its peers.

Aster Fundamentals

Return On Equity0.0699
Return On Asset0.0255
Profit Margin1.28 %
Operating Margin0.12 %
Current Valuation217.03 B
Shares Outstanding498.13 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110%20%30%40%50%
Shares Owned By Insiders54.01 %
Shares Owned By Institutions32.88 %
Price To Book6.16 X
Price To Sales5.22 X
Revenue36.99 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%500%
Gross Profit22.83 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
EBITDA6.12 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%
Net Income1.29 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%0%100%200%300%400%
Cash And Equivalents500.3 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%300%
Total Debt13.84 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
Book Value Per Share68.82 X
Cash Flow From Operations1.58 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%500%600%700%
Earnings Per Share4.09 X
Target Price576.78
Number Of Employees14.02 K
Beta0.62
Market Capitalization214.52 B
Total Asset179.91 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%
Retained Earnings4.21 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-600%-400%-200%0%200%400%
Working Capital28.77 B
Annual Yield0.02 %
Net Asset179.91 B

About Aster DM Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Aster DM Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aster DM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aster DM Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Aster Stock

Aster DM financial ratios help investors to determine whether Aster Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aster with respect to the benefits of owning Aster DM security.


 

Trending Assets

MAHASTEEL
Mahamaya Steel Industries
240.00  -1  -0.41 
RAMASTEEL
Rama Steel Tubes
10.08  0.40  4.13 
MSPL
MSP Steel Power
28.11  0.86  3.16 
LICI
Life Insurance
776.75  31.35  4.21 
STEELCAS
Steelcast Limited
1,047  14.10  1.36 
JSWSTEEL
JSW Steel Limited
1,033  27.65  2.75 
SHYAMTEL
Shyam Telecom Limited
12.79  -0.02  -0.16 
KSL
Kalyani Steels
784.30  59.70  8.24 
News Freq…Investor S…